Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
AXNX

AXNX - Axonics Modulation Technologies Inc Stock Price, Fair Value and News

$70.98 
Market Closed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

AXNX Price Action

AXNX RSI Chart

AXNX Valuation

AXNX Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

AXNX Fundamentals

AXNX Revenue

AXNX Earnings

AXNX Profitability

AXNX Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024387.1M408.8M431.9M0
2023295.9M319.8M342.6M366.4M
2022194.3M217.4M240.9M273.7M
2021119.6M150.3M161.9M180.3M
202039.0M52.8M86.7M111.5M
20192.0M3.3M4.4M13.8M
20180369.7K538.3K707.0K
2017000201.0K
Get all data in R, Python etc through our Historical Stock Data APIs

About Axonics Modulation Technologies Inc

AXNX
Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. reduce the symptoms of OAB, UR, and FI. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct sales force and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.
 CEO
 WEBSITEaxonics.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES610